undamentalytics Newsletter
Sign in

Standard Biotools Inc. balance sheet

At the end of fiscal 2025, Standard Biotools Inc. had total assets of $568m, total liabilities of $143m and shareholders' equity of $424m. It held $121m in cash against $299,000 of debt: net cash of $121m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents15614593534293558952269288152167121270
Receivables—89131122251515171925181720151316
Inventory—567816182015131420212121212017
Total current assets—217010110515614497951279611872209158376454517
Goodwill————0104104104104104104107106106106111——
Total assets—2579114117408370306288304265325275390323612568627
Accounts payable—3434664445911895510
Deferred revenue (current)—12237991011121312111210399
Total current liabilities—192012182930303338335450431096610857
Short-term debt—590——————————————
Long-term debt—1010019519519519517254545465640——
Total debt01810001951951951951725454616564000
Total liabilities—2922132125725525325623211118618116116014114387
Shareholders' equity−174−189571019615011553317215413995−81−148472424540
Non-controlling interests and other (assets − liabilities − equity)—185———————————311311———
Net debt (negative = net cash)−1512−3−59−351621661601377732−1433−1612−166−121−270
Shares outstanding—19m20m25m26m28m29m29m39m49m70m75m77m79m80m378m386m392m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: HBIO vs LABCDXS vs LABBNR vs LAB

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Standard Biotools Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Standard Biotools Inc.